Biotech News
Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results
ir.arrowheadpharma.com2026-05-06 14:45 EST
- Conference Call and Webcast Today, February 5, 2026, at 4:30 p.m. ET PASADENA, Calif. --(BUSINESS WIRE)--Feb. 5, 2026-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 first quarter ended December 31, 2025.